FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area

被引：20
|
作者：
von Maessenhausen, Anne [1 ]
Franzen, Alina [1 ]
Heasley, Lynn [2 ]
Perner, Sven [1 ]
机构：
[1] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany
[2] Univ Colorado, Dept Craniofacial Biol, Aurora, CO USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2013年 / 1卷 / 03期
关键词：
FGFR1; lung cancer; head and neck cancer; therapeutic target; biomarker;
D O I：
10.3978/j.issn.2305-5839.2013.06.08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FGFR1 amplification is a genomic aberration recently identified in various types of cancer. Especially squamous cell carcinomas of the lung and the head and neck show this genetic alteration in high frequencies. In these cancers FGFR1 is not only a therapeutic target but does also serve as a biomarker that correlates with parameters of worse outcome. However, since FGFR1 amplification does not always correlate with high protein expression defining the best predictive biomarker for a FGFR1 targeted therapy is of great importance.
引用
收藏
页数：3
相关论文
共 50 条
  • [11] MYCxing It Up with FGFR1 in Squamous Cell Lung Cancer
    Lockwood, William
    Politi, Katerina
    CANCER DISCOVERY, 2014, 4 (02) : 152 - 154
  • [12] FGFR1 amplification in metastatic squamous cell carcinoma of the head and neck: A potential target for a rational therapy?
    Goeke, F.
    Franzen, A.
    Menon, R.
    Schroeck, A.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Bootz, F.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S49 - S49
  • [13] FGFR1 Amplification in Metastatic Squamous Cell Carcinoma of the Head and Neck - a Potential Target for a Rational Therapy?
    Goeke, F.
    Franzen, A.
    Menon, R.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Bootz, F.
    Schroeck, A.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S196 - S196
  • [14] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Clauditz, Till Sebastian
    Boettcher, Arne
    Hanken, Henning
    Borgmann, Kerstin
    Sauter, Guido
    Wilczak, Waldemar
    Grob, Tobias
    Muenscher, Adrian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (01) : 53 - 61
  • [15] FGFR1 Amplification in Metastatic Squamous Cell Carcinoma of the Head and Neck A Potential Target for a Rational Therapy?
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Bootz, F.
    Schroeck, A.
    Perner, S.
    MODERN PATHOLOGY, 2012, 25 : 309A - 309A
  • [16] FGFR1 Amplification in Metastatic Squamous Cell Carcinoma of the Head and Neck - A Potential Target for a Rational Therapy?
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Bootz, F.
    Schroeck, A.
    Perner, S.
    LABORATORY INVESTIGATION, 2012, 92 : 309A - 309A
  • [17] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Till Sebastian Clauditz
    Arne Böttcher
    Henning Hanken
    Kerstin Borgmann
    Guido Sauter
    Waldemar Wilczak
    Tobias Grob
    Adrian Münscher
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 53 - 61
  • [18] Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma
    Si, Yishimei
    Meng, Linghan
    Zhang, Bingwen
    Qi, Jianwei
    ASIAN JOURNAL OF SURGERY, 2023, 46 (10) : 4425 - 4427
  • [19] Predicting prognosis in cancers of the lung and head and neck with a novel biomarker
    Brown, Emily
    FUTURE ONCOLOGY, 2014, 10 (07) : 1118 - 1118
  • [20] EXT2: a novel prognostic and predictive biomarker for head and neck cell carcinoma
    Selvan, Angel Jenifer Arul
    Kannan, Balachander
    Pandi, Chandra
    Jayaseelan, Vijayashree Priyadharsini
    Arumugam, Paramasivam
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2024, 137 (03): : 282 - 289
12345